“…During the progression of aging-associated degeneration diseases, altered cell fate of adult stem cells, or dysfunction of terminally differentiated mature cells occurs, which may result from the changed ECM niche modified with aging-related proteins and reduced expression of ECM-synthesis-associated proteins (Goupille et al, 1998;Chan et al, 2006;Sakai et al, 2012;Wang et al, 2015;Jeon et al, 2017;Patil et al, 2019), which may be correlated with the LOX family members. Therefore, reverting aging-associated genes in ECM may become an important strategy for joint rejuvenation (Chan et al, 2006;Fuoco et al, 2014;Li et al, 2014;Sun et al, 2011;Wang et al, 2019;Zhou J. et al, 2019). Modulation of expression of LOXs family members through transcriptional regulation of HIF-1 may become promising therapeutic approaches for treating aging-induced cartilage degeneration as potential rejuvenating therapies.…”